Literature DB >> 28450275

Evolution of biological agents: how established drugs can become less safe.

Nicole Casadevall1, Oliver Flossmann2, David Hunt3.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28450275     DOI： 10.1136/bmj.j1707

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  Performance of Janus kinase inhibitors in psoriatic arthritis with axial involvement in indirect comparison with ankylosing spondylitis: a retrospective analysis from pooled data.

Authors:  Lin Wang; Xiaofang Ping; Wei Chen; Weibin Xing
Journal:  Clin Rheumatol       Date:  2020-10-17       Impact factor: 2.980

Review 2.  Established and Emerging Immunological Complications of Biological Therapeutics in Multiple Sclerosis.

Authors:  Babak Soleimani; Katy Murray; David Hunt
Journal:  Drug Saf       Date:  2019-08       Impact factor: 5.606
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.